Abraxane and dehydration Patient Reports February 11, 2012

Abraxane Side Effects Report #5912172-8
Abraxane side effect was reported by a Health Professional from UNITED STATES on Oct 03, 2008. Female patient, weighting 122.4 lb, was diagnosed with uterine cancer  and was treated with Abraxane. After drug was administered, patient experienced the following side effects: clostridial infection, dehydration, lobar pneumonia. Abraxane dosage: 395 MG D1/CYCLE 042. During the same period patient was treated with VANDETANIB, CIPROFLOXACIN, METFORMIN, TYLENOL W, FERROUS SULPHATE, CALCIUM, FLAGYL, CLINDAMYCIN. Patient was hospitalized. Patient recovered.

Abraxane Side Effects Report #5023726-8
Abraxane side effect was reported by a Physician from UNITED STATES on Mar 14, 2006. Male patient, 83 years of age, weighting 127.0 lb, was diagnosed with non-small cell lung cancer and was treated with Abraxane. After drug was administered, patient experienced the following side effects: asthenia, azotaemia, blood chloride decreased, blood sodium decreased, chronic obstructive pulmonary disease, condition aggravated, dehydration, dysphagia, epistaxis. Abraxane dosage: 462 MG EVERY 3 WEEKS; OFF STUDY. During the same period patient was treated with CARBOPLATIN, AVASTIN, CRESTOR, TOPROL, ASPIRIN. Patient was hospitalized. Patient died on 03/17/2006.

Abraxane Side Effects Report #5961044-1
Abraxane side effect was reported by a Physician from UNITED STATES on Nov 05, 2008. Male patient, 69 years of age, weighting 179.9 lb, was diagnosed with metastatic malignant melanoma and was treated with Abraxane. After drug was administered, patient experienced the following side effects: atrial fibrillation , calculus ureteric, dehydration, tachycardia. Abraxane dosage: LAST DOSE PRIOR TO SAE 15SEP08 307.5MG (307.5 MG). During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized. Patient recovered.

Abraxane Side Effects Report #6002600-4
Abraxane side effect was reported by a Physician from UNITED STATES on Dec 01, 2008. Male patient, 69 years of age, weighting 179.9 lb, was diagnosed with metastatic malignant melanoma and was treated with Abraxane. After drug was administered, patient experienced the following side effects: asthenia, atrial fibrillation , blood pressure systolic decreased, calculus ureteric, chest pain , dehydration, dyspnoea, haematocrit decreased, haemoglobin decreased. Abraxane dosage: LAST DOSE PRIOR TO SAE 15SEP08 307.5MG (307.5 MG), INTRAVENOUS. During the same period patient was treated with BEVACIZUMAB, TOPAMAX, ELAVIL, LIPITOR, CELEBREX, PROZAC, PROTONIX, VICODIN. Patient was hospitalized. Patient recovered.


Abraxane Side Effects Report #5573590-3
Abraxane side effect was reported by a Health Professional from UNITED STATES on Dec 05, 2007. Female patient, 83 years of age, weighting 150.5 lb, was diagnosed with breast cancer metastatic and was treated with Abraxane. After drug was administered, patient experienced the following side effects: arrhythmia , asthenia, blood culture positive, blood glucose increased, blood urea increased, cardiac failure congestive, confusional state, dehydration, diarrhoea. Abraxane dosage: 216 MG DAY EVERY 21 DAY, INTRAVENOUS DRIP. During the same period patient was treated with CAPECITABINE, ALTACE, HYDROCHLOROTHIAZIDE, TRICOR, HUMULIN, AMBIEN, DILAUDID, LEVOXYL. Patient was hospitalized. Patient recovered.

Abraxane Side Effects Report #5131458-0
Abraxane side effect was reported by a Health Professional from UNITED STATES on Oct 02, 2006. Male patient, 66 years of age, weighting 223.8 lb, was diagnosed with breast cancer metastatic, anaemia of malignant disease, hypercholesterolaemia, neutropenia and was treated with Abraxane. After drug was administered, patient experienced the following side effects: anaemia, cardiac failure congestive, chest pain , dehydration, dyspnoea, musculoskeletal chest pain, neutropenia, palpitations, pneumonia . Abraxane dosage: LAST DOSE PRIOR TO FIRST EVENT 28-APR-2006 (175 MG/M2, EVERY 3 WEEKS), INTRAVENOUS DRIP. During the same period patient was treated with PROCRIT, CYTOXAN, DOXORUBICIN, ASPIRIN, NEUPOGEN, LIPITOR, LORTAB. Patient was hospitalized. Patient recovered.

Abraxane Side Effects Report #5135641-X
Abraxane side effect was reported by a Health Professional from UNITED STATES on Oct 10, 2006. Male patient, 66 years of age, weighting 223.8 lb, was diagnosed with breast cancer metastatic, anaemia of malignant disease, hypercholesterolaemia, neutropenia and was treated with Abraxane. After drug was administered, patient experienced the following side effects: anaemia of malignant disease, arrhythmia supraventricular, bone pain, cardiac failure congestive, dehydration, febrile neutropenia, fluid overload, gallbladder polyp, gastrooesophageal reflux disease. Abraxane dosage: LAST DOSE PRIOT TO FIRST EVENT 28-APR 2006 (175 MG/M2, EVERY 3 WEEKS), INTRAVENOUS DRIP. During the same period patient was treated with PROCRIT, CYTOXAN, DOXORUBICIN, ASPIRIN, NEUPOGEN, LIPITOR, LORTAB. Patient was hospitalized. Patient recovered.

Abraxane Side Effects Report #6009136-5
Abraxane side effect was reported by a Physician from UNITED STATES on Dec 04, 2008. Female patient, 62 years of age, weighting 310.0 lb, was diagnosed with breast cancer metastatic, hypertension and was treated with Abraxane. After drug was administered, patient experienced the following side effects: arthralgia, blood bilirubin increased, blood calcium decreased, blood pressure diastolic decreased, blood sodium decreased, carbon dioxide decreased, constipation , dehydration, haematocrit decreased. Abraxane dosage: (125 MG/M2, 9 WEEK). During the same period patient was treated with NEXAVAR, HYDROCHLOROTHIAZIDE, MOBIC, VISTERIL, LORTAB, VITAMIN, CALCIUM. Patient was hospitalized. Patient recovered.

Abraxane Side Effects Report #5096641-1
Abraxane side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 17, 2006. Female patient, 47 years of age, was diagnosed with breast cancer metastatic and was treated with Abraxane. After drug was administered, patient experienced the following side effects: dehydration, neutropenia. Abraxane dosage: 155MG X 1 DOSE (EVERY 3 WEEKS) INTRAVENUOS DRIP. During the same period patient was treated with AVASTIN, CARBOPLATIN. Patient was hospitalized. Patient recovered.


Abraxane Side Effects Report #5096988-9
Abraxane side effect was reported by a Health Professional from UNITED STATES on Aug 17, 2006. Male patient, 47 years of age, weighting 112.0 lb, was diagnosed with breast cancer metastatic and was treated with Abraxane. After drug was administered, patient experienced the following side effects: dehydration, liver function test abnormal, neutropenia. Abraxane dosage: 155MG X 1 DOSE (EVERY 3 WEEKS), INTRAVENOUS DRIP. During the same period patient was treated with AVASTIN, CARBOPLATIN. Patient was hospitalized. Patient recovered.

Abraxane Side Effects Report #5104936-8
Abraxane side effect was reported by a Health Professional from UNITED STATES on Aug 29, 2006. Female patient, 47 years of age, weighting 112.0 lb, was diagnosed with breast cancer metastatic and was treated with Abraxane. After drug was administered, patient experienced the following side effects: abscess limb, anaemia, blood calcium decreased, blood chloride increased, blood glucose increased, blood potassium increased, blood urea increased, dehydration, electrolyte imbalance. Abraxane dosage: 155MG X 1 DOSE (SCHEDULED EVERY 3 WEEKS), INTRAVENOUS DRIP. During the same period patient was treated with CARBOPLATIN, AVASTIN, NEXIUM, ADVIL, OXYCODONE. Patient was hospitalized. Patient recovered.

Abraxane Side Effects Report #5049775-1
Abraxane side effect was reported by a Health Professional from UNITED STATES on June 22, 2006. Female patient, 45 years of age, weighting 160.0 lb, was diagnosed with breast cancer metastatic and was treated with Abraxane. After drug was administered, patient experienced the following side effects: catheter related infection, dehydration, mucosal inflammation, neutropenia, oral mucosal blistering, rash , sepsis , thrombocytopenia. Abraxane dosage: unknown. During the same period patient was treated with CARBOPLATIN, NEULASTA. Patient was hospitalized. Patient recovered.

Abraxane Side Effects Report #5200254-8
Abraxane side effect was reported by a Health Professional from UNITED STATES on Dec 20, 2006. Female patient, 61 years of age, weighting 175.2 lb, was diagnosed with breast cancer  and was treated with Abraxane. After drug was administered, patient experienced the following side effects: anorexia, dehydration, fatigue, hypokalaemia. Abraxane dosage: 338 MG/CYCLE 5, DAY 20 (175 MG/M2), INTRAVENOUS. During the same period patient was treated with EPIRUBICIN, GEMCITABINE, COUMADIN, DIOVAN, TOPROL. Patient was hospitalized. Patient recovered.

Abraxane Side Effects Report #5227176-0
Abraxane side effect was reported by a Health Professional from UNITED STATES on Jan 17, 2007. Female patient, 61 years of age, weighting 175.2 lb, was diagnosed with breast cancer  and was treated with Abraxane. After drug was administered, patient experienced the following side effects: anorexia, dehydration, fatigue, haematocrit decreased, haemoglobin decreased, hypokalaemia, international normalised ratio increased, prothrombin time prolonged, white blood cell count decreased. Abraxane dosage: 338 MG/ CYCLE 5, DAY 20/ DATE OF LAST DOSE GIVEN 27NOV06 (175 MG/M2), INTRAVENOUS. During the same period patient was treated with EPIRUBICIN, GEMCITABINE, COUMADIN, DIOVAN, TOPROL. Patient was hospitalized. Patient recovered.


Abraxane Side Effects Report #5319046-4
Abraxane side effect was reported by a Physician from UNITED STATES on Apr 16, 2007. Female patient, 59 years of age, weighting 319.7 lb, was diagnosed with breast cancer  and was treated with Abraxane. After drug was administered, patient experienced the following side effects: blood bilirubin increased, dehydration, mucosal inflammation, pain , pharyngolaryngeal pain. Abraxane dosage: unknown. Patient was hospitalized. Patient recovered.

Abraxane Side Effects Report #5325859-5
Abraxane side effect was reported by a Physician from UNITED STATES on Apr 25, 2007. Female patient, 59 years of age, weighting 145.0 lb, was diagnosed with breast cancer  and was treated with Abraxane. After drug was administered, patient experienced the following side effects: blood bilirubin increased, dehydration, leukopenia, liver function test abnormal, mucosal inflammation, pain , pharyngolaryngeal pain. Abraxane dosage: LAST DOSE PRIOR TO SAE (CYCLE 2, 110 MG/M2) , INTRAVENOUS. Patient was hospitalized. Patient recovered.